Impact of infectious-disease specialist consultations on outcomes of Staphylococcus aureus bacteremia in a hospital with a low volume of patients with S. aureus bacteremia

Journal of Infection

Volumn 62, Issue 2, 2011, Pages 181-185

  Choi, Seong Ho ^a   Cho, Sun Young ^a   Park, Ji Hoon ^a   Chung, Jin Won ^a  

^a Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; GLUCOCORTICOID; POLYPEPTIDE ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; BLOOD CULTURE; CATHETER INFECTION; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NEUTROPENIA; PROGNOSIS; RETROSPECTIVE STUDY; SOLID TUMOR; SOUTH KOREA; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; FEMALE; HUMANS; INFECTIOUS DISEASE MEDICINE; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SPECIALIZATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 79551589249     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.12.002     Document Type: Letter

References (18)

1. Fowler V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293(24):3012-3021.
2. Chang F.Y., MacDonald B.B., Peacock J.E., Musher D.M., Triplett P., Mylotte J.M., et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 2003, 82(5):322-332.
3. Fowler V.G., Olsen M.K., Corey G.R., Woods C.W., Cabell C.H., Leller L.B., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003, 163(17):2066-2072.
4. Rieg S., Peyerl-Hoffmann G., de With K., Wagner D., Hübner J., Dettenkofer M., et al. Mortality of Staphylococcus aureus bacteremia and infectious diseases specialist consultation - a study of 521 patients in Germany. J Infect 2009, 59:232-239.
5. Honda H., Krauss M.J., Jones J.C., Olsen M.A., Warren D.K. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 2010, 123:631-637.
6. Lahey T., Shah R., Gittzus J., Schwartzman J., Kirkland K. Infectious diseases consultation lower mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore) 2009, 88(5):263-267.
7. Kaech C., Elzi L., Sendi P., Frei R., Laifer G., Bassetti S., et al. Course and outcome of Staphylococcus aureus bacteremia: a retrospective analysis of 308 patients in a Swiss tertiary-care centre. Clin Microbiol Infect 2006, 12:345-352.
8. Kern W.V. Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis 2010, 23:346-358.
9. Bone R.C., Sibbald W.J., Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101:1481-1483.
10. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
11. Peterson D.L., Ko W.C., Gottberg A.V., Mohapatra S., Casellas J.M., Goossens H., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infection. Ann Intern Med 2004, 140:26-32.
12. Fowler V.G., Sanders L.L., Sexton D.J., Kong L., Marr K.A., Gopal A.K., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998, 27:478-486.
13. Jenkins T.C., Price C.S., Sabel A.L., Mehler P.S., Burman W.J. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008, 46:1000-1008.
14. Ross J.S., Normand S.T., Wang Y., Ko D.T., Chen J., Drye E.E., et al. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med 2010, 362:1110-1118.
15. Halm E.A., Lee C., Chassin M.R. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002, 137:511-520.
16. Wyllie D.H., Crook D.W., Peto T.E. Mortality after Staphylococcus aureus bacteremia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006, 333:281-286.
17. Lillie P., Moss P., Thaker H., Parsonage M., Adams K., Meigh J., et al. Development, impact and outcomes of the Hull bacteremia service. Q J Med 2008, 101:889-898.
18. Choi S.H., Lee S.O., Choi J.P., Chung J.W., Choi S.H., Jeong J.Y., et al. The clinical significance of concurrent Staphylococcus aureus bacteriuria in patients with S. aureus bacteremia. J Infect 2009, 59:37-41.